Agilon Health (AGL) closed at $110.30 on November 12, 2026, down 3.9% from the previous close, on volume of 155,361 shares (30-day average 205,720).
Data as of November 12, 2026.
12-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 26, 2026 | Put with Delta Hedge | 20-Nov-26 85 P +1,920 Stock | 200 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 12, 2026. See the 10 largest for 30, 60 and 90 days
Business Wire (Thu, 5-Nov 7:30 AM ET)
agilon health Reports Third Quarter 2026 Results
Business Wire (Wed, 4-Nov 4:05 PM ET)
agilon health Sets Date to Report Third Quarter 2026 Financial Results
Business Wire (Mon, 5-Oct 4:05 PM ET)
agilon health and The Jackson Clinic Advance Their Partnership Through Senior Health Connect ACO
Business Wire (Wed, 30-Sep 9:00 AM ET)
Market Chameleon (Thu, 24-Sep 7:51 AM ET)
agilon health and Springfield Clinic Broaden Partnership Through Senior Health Connect ACO
Business Wire (Wed, 23-Sep 9:00 AM ET)
agilon health and Family Practice Center Expand Relationship Through Senior Health Connect ACO
Business Wire (Thu, 10-Sep 9:00 AM ET)
Business Wire (Thu, 27-Aug 4:05 PM ET)
agilon health to Participate in Upcoming Conferences
Business Wire (Thu, 20-Aug 4:05 PM ET)
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.
Agilon Health trades on the NYSE stock market under the symbol AGL.
As of November 12, 2026, AGL stock price declined to $110.30 with 155,361 million shares trading.
AGL has a beta of 4.66, meaning it tends to be more sensitive to market movements. AGL has a correlation of 0.15 to the broad based SPY ETF.
AGL has a market cap of $1.84 billion. This is considered a Small Cap stock.
Last quarter Agilon Health reported $2 billion in Revenue and $1.97 earnings per share. This beat revenue expectation by $60 million and exceeded earnings estimates by $2.96.
In the last 3 years, AGL traded as high as $344.00 and as low as $7.48.
The top ETF exchange traded funds that AGL belongs to (by Net Assets): IWM, VTI, FNDA, IWO, FYC.
AGL has outperformed the market in the last year with a price return of +602.8% while the SPY ETF gained +11.9%. AGL has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +27.9% and +28.3%, respectively, while the SPY returned -1.7% and -1.6%, respectively.
AGL support price is $110.46 and resistance is $119.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AGL shares will trade within this expected range on the day.
